Chris Bahl

Contact Chris

Chris Bahl

President

AI Proteins

C.D. Bahl holds the position of President at AI Proteins, a company likely involved in the field of artificial intelligence applied to protein research. As President, C.D. Bahl plays a pivotal role in leading the strategic direction of AI Proteins, overseeing operations, and contributing to the company's growth and success. His responsibilities likely include guiding the implementation of AI technologies in protein-related research and applications. C.D. Bahl's leadership underscores his commitment to advancing the integration of artificial intelligence in the field of proteins, potentially leading to innovative solutions and breakthroughs. His role as President reflects his dedication to shaping the trajectory of AI Proteins within the evolving landscape of biotechnology.

Talks About
#strategicleadership #operationaloversight #aiintegrationinbiotechnology

Preferred Locations
#NorthAmerica

Speaking Engagements

Next Generation Protein Therapeutics Summit 2022

Paid

Next Generation Protein Therapeutics conference brings together antibody and protein engineers and novel biologics discovery and R&D scientists who are interested in sharing strategies to accelerate the next wave of protein therapeutics from discovery to clinic to market.

28-30 September 2022

Healthcare

PepTalk 2024

Paid

The Protein Science and Production Week PepTalk provides a comprehensive program and innovative solutions for optimizing biotherapeutics. Conference tracks cover a range of topics including antibody engineering, bispecific antibody development, characterization of biologics, viral vector engineering, and protein expression platforms. Learn from exp

16-19 January 2024

Healthcare

Claim Your Profile Request

Speaker Contact Request

SPEAKER

Chris Bahl

President

Speaking Engagements

Next Generation Protein Therapeutics Summit 2022

PepTalk 2024